KC-764
KC-764 is an orally active, reversible cyclooxygenase inhibitor with relative selectivity for platelet cyclooxygenase. KC-764 inhibits platelet thromboxane A2 (TXA2) production and platelet aggregation, with IC50s of 0.23 μM and 26 nM, respectively. KC-764 can be used for the research on antiplatelet and recurrence prevention in ischemic stroke.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 94457-09-7
- Formel: C14H15N3O
- Molecular Weight:241.29
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
TXA2 |
Chemical Information
-
CAS. Nr. 94457-09-7
-
Molecular Weight 241.29
-
Formel C14H15N3O
-
SMILES
O=C(C1=C2C=CC=CN2N=C1C)C3=CNCCC3
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
KC-764 Related Classifications
HY-100484 Related Classifications
Powered by Bioz